Shared Decision Making: Aids and Promotion in Clinical Practice Guidelines for Type 2 Diabetes Treatment
Journal of Evaluation in Clinical Practice · 2026-06 · 32 (4)
DOI: 10.1111/jep.70457 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Evaluation in Clinical Practice, online erschienen am 15.05.2026. Verfasst von Yves Marie Vincent und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Bordeaux University, Bordeaux, France. Hauptthemen laut MEDLINE: Decision Making, Shared, Decision Support Techniques, Diabetes Mellitus, Type 2, Patient Participation. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Type 2 diabetes (T2D) is a major global health issue due to its rising prevalence and significant burden in terms of morbidity, mortality, and economic impact. Although the availability of Clinical Practice Guidelines (CPGs) aimed at optimising T2D management, the complexity of therapeutic options and the necessity of tailoring treatment to individual patient preferences pose ongoing challenges. Shared Decision Making (SDM) and the high‐quality decision aids have been shown to enhance patient understanding and engagement in medical decisions. This study aimed to assess the presence of decision aids and the promotion of SDM within international and national CPGs for T2D treatment.
Methods
Fifty‐two CPGs identified in a prior systematic review were re‐evaluated. Following the application of exclusion criteria and review of updates, 33 CPGs from 20 countries were included. The analysis focused on identifying high‐quality decision aids—defined as those providing absolute risk estimates for therapeutic options—and on detecting explicit support for SDM using predefined key terms.
Results
No CPGs included decision aids that met the criteria for high quality. However, 73% acknowledged the importance of patient values and preferences, incorporating at least one reference to SDM. Despite this, no tools were provided to facilitate the practical implementation of SDM. This finding underscores a persistent gap between the theoretical recognition of SDM and its operational integration into CPGs.
Discussion
These findings suggest that although the role of SDM is theoretically embraced, its practical application remains insufficient. Efforts from major guideline‐developing organisations to improve methodological inclusion of patient‐centred elements are encouraging, yet much progress is needed. Future guideline development must prioritise the integration of rigorously designed decision aids to truly support informed, value‐based medical decisions in T2D care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General Medicine, Bordeaux University, Bordeaux, France.
- Claude Bernard Lyon 1 University, Lyon, France.
- Department of General Medicine, Poitiers University, Poitiers, France.
- UMR 5558, CNRS, LBBE, EMET, Claude Bernard Lyon 1 University, Lyon, France.
ORCID-Profile: Rémy Boussageon
Zitieren
APA
Vincent, Y. M., Kasbi, M., Saouli, R., Clara, B., & Boussageon, R. (2026). Shared Decision Making: Aids and Promotion in Clinical Practice Guidelines for Type 2 Diabetes Treatment. Journal of Evaluation in Clinical Practice, 32(4). https://doi.org/10.1111/jep.70457
Vancouver
Vincent YM, Kasbi M, Saouli R, Clara B, Boussageon R. Shared Decision Making: Aids and Promotion in Clinical Practice Guidelines for Type 2 Diabetes Treatment. Journal of Evaluation in Clinical Practice. 2026;32(4). doi:10.1111/jep.70457
BibTeX
@article{Vincent2026,
author = {Vincent, Yves Marie and Kasbi, Merwan and Saouli, Reda and Clara, Blanchard and Boussageon, Rémy},
title = {Shared Decision Making: Aids and Promotion in Clinical Practice Guidelines for Type 2 Diabetes Treatment},
journal = {Journal of Evaluation in Clinical Practice},
year = {2026},
volume = {32},
number = {4},
doi = {10.1111/jep.70457}
}
EUVIMED